Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

Published:2008-11 Issue:9651 Volume:372 Page:1746-1755
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Näntö-Salonen Kirsti,Kupila Antti,Simell Satu,Siljander Heli,Salonsaari Tiina,Hekkala Anne,Korhonen Sari,Erkkola Risto,Sipilä Jukka I,Haavisto Lotta,Siltala Marja,Tuominen Juhani,Hakalax Jari,Hyöty Heikki,Ilonen Jorma,Veijola Riitta,Simell Tuula,Knip Mikael,Simell Olli

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment;Atkinson;Lancet,2001

2. Environmental triggers and determinants of type 1 diabetes;Knip;Diabetes,2005

3. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice;Karounos;J Clin Invest,1997

4. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro;Tiittanen;Diabetes,2006

5. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM;Bowman;Diabetes,1996

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric study of global trends in T1DM and intestinal flora research;Frontiers in Microbiology;2024-07-04

2. Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07);Diabetes Care;2024-07-01

3. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials;Diabetes/Metabolism Research and Reviews;2024-05

4. From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes;Expert Review of Endocrinology & Metabolism;2024-05

5. Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review;Communications Medicine;2024-04-06